Display options
Cite
Serra G, Demontis F, Serra F, et al. Memantine: New prospective in bipolar disorder treatment. World J Psychiatry. 2014;4(4):80-90doi: 10.5498/wjp.v4.i4.80.
Serra, G., Demontis, F., Serra, F., De Chiara, L., Spoto, A., Girardi, P., Vidotto, G., & Serra, G. (2014). Memantine: New prospective in bipolar disorder treatment. World journal of psychiatry, 4(4), 80-90. https://doi.org/10.5498/wjp.v4.i4.80
Serra, Giulia, et al. "Memantine: New prospective in bipolar disorder treatment." World journal of psychiatry vol. 4,4 (2014): 80-90. doi: https://doi.org/10.5498/wjp.v4.i4.80
Serra G, Demontis F, Serra F, De Chiara L, Spoto A, Girardi P, Vidotto G, Serra G. Memantine: New prospective in bipolar disorder treatment. World J Psychiatry. 2014 Dec 22;4(4):80-90. doi: 10.5498/wjp.v4.i4.80. PMID: 25540723; PMCID: PMC4274590.
Copy Download .nbib Format: NLM
Share it on

World J Psychiatry. 2014 Dec 22;4(4):80-90. doi: 10.5498/wjp.v4.i4.80.

Memantine: New prospective in bipolar disorder treatment.

World journal of psychiatry

Giulia Serra, Francesca Demontis, Francesca Serra, Lavinia De Chiara, Andrea Spoto, Paolo Girardi, Giulio Vidotto, Gino Serra

Affiliations

  1. Giulia Serra, Department of Psychiatry, Harvard Medical School, Boston, MA 02115, United States.

PMID: 25540723 PMCID: PMC4274590 DOI: 10.5498/wjp.v4.i4.80

Abstract

UNLABELLED: We review preclinical and clinical evidences strongly suggesting that memantine, an old drug currently approved for Alzheimer's dementia, is an effective treatment for acute mania and for the prevention of manic/hypomanic and depressive recurrences of manic-depressive illness. Lithium remains the first line for the treatment and prophylaxis of bipolar disorders, but currently available treatment alternatives for lithium resistant patients are of limited and/or questionable efficacy. Thus, research and development of more effective mood stabilizer drugs is a leading challenge for modern psychopharmacology. We have demonstrated that 21 d administration of imipramine causes a behavioural syndrome similar to a cycle of bipolar disorder, i.e., a mania followed by a depression, in rats. Indeed, such treatment causes a behavioural supersensitivity to dopamine D2 receptor agonists associated with an increase sexual activity and aggressivity (mania). The dopamine receptor sensitization is followed, after imipramine discontinuation, by an opposite phenomenon (dopamine receptor desensitization) and an increased immobility time (depression) in the forced swimming test of depression. Memantine blocks the development of the supersensitivity and the ensuing desensitization associated with the depressive like behavior. On the basis of these observations we have suggested the use of memantine in the treatment of mania and in the prophylaxis of bipolar disorders. To test this hypothesis we performed several naturalistic studies that showed an acute antimanic effect and a long-lasting and progressive mood-stabilizing action (at least 3 years), without clinically relevant side effects. To confirm the observations of our naturalistic trials we are now performing a randomized controlled clinical trial. Finally we described the studies reporting the efficacy of memantine in manic-like symptoms occurring in psychiatric disorders other than bipolar.

LIMITATIONS: A randomized controlled clinical trial is needed to confirm our naturalistic observations.

CONCLUSION: We believe that this review presents enough pharmacological and clinical information to consider the administration of memantine in the treatment of bipolar disorders that no respond to standard mood stabilizers.

Keywords: Bipolar disorder; Depression; Manic symptoms; Memantine; Mood stabilizer

References

  1. Psychopharmacology (Berl). 2002 Jun;161(4):370-8 - PubMed
  2. Pharmacol Toxicol. 1992;71 Suppl 1:72-85 - PubMed
  3. Bipolar Disord. 2009 Dec;11(8):787-806 - PubMed
  4. Bipolar Disord. 2012 Feb;14(1):64-70 - PubMed
  5. Eur J Pharmacol. 1997 Mar 19;322(2-3):123-7 - PubMed
  6. J Psychiatr Pract. 2011 Jul;17(4):292-9 - PubMed
  7. Prog Drug Res. 1998;50:155-92 - PubMed
  8. Brain Res Bull. 2000 Apr;51(6):485-92 - PubMed
  9. Eur Neuropsychopharmacol. 1999 Dec;9(6):507-14 - PubMed
  10. Can J Psychiatry. 2014 Aug;59(8):401-5 - PubMed
  11. Ther Adv Psychopharmacol. 2014 Feb;4(1):53-5 - PubMed
  12. Alcohol Clin Exp Res. 2000 Mar;24(3):285-90 - PubMed
  13. Bipolar Disord. 2010 May;12(3):264-70 - PubMed
  14. Alzheimers Dement. 2008 Jan;4(1):49-60 - PubMed
  15. J Clin Psychiatry. 2015 Jan;76(1):e91-7 - PubMed
  16. Arch Gen Psychiatry. 1969 Aug;21(2):240-8 - PubMed
  17. J Neuropsychiatry Clin Neurosci. 2007 Fall;19(4):406-12 - PubMed
  18. Am J Psychiatry. 1965 Nov;122(5):509-22 - PubMed
  19. Neurocase. 2010 Oct;16(5):436-50 - PubMed
  20. Behav Brain Res. 2004 May 5;151(1-2):201-8 - PubMed
  21. Eur J Pharmacol. 2001 Mar 23;416(1-2):107-11 - PubMed
  22. Behav Res Methods. 2010 Feb;42(1):342-50 - PubMed
  23. Synapse. 1994 Feb;16(2):137-47 - PubMed
  24. Arch Gen Psychiatry. 2007 Mar;64(3):327-37 - PubMed
  25. Pharmakopsychiatr Neuropsychopharmakol. 1980 Jul;13(4):156-67 - PubMed
  26. J Neurosci. 2005 Jul 13;25(28):6651-7 - PubMed
  27. Psychopharmacology (Berl). 1984;83(1):1-16 - PubMed
  28. Riv Psichiatr. 2014 Jul-Aug;49(4):192-4 - PubMed
  29. J Neuropsychiatry Clin Neurosci. 2014 Winter;26(1):E21-2 - PubMed
  30. Curr Neuropharmacol. 2008 Mar;6(1):55-78 - PubMed
  31. Case Rep Psychiatry. 2012;2012:749796 - PubMed
  32. Eur J Pharmacol. 2003 Jan 1;458(1-2):129-34 - PubMed
  33. J Clin Psychopharmacol. 2013 Oct;33(5):715-7 - PubMed
  34. PLoS One. 2014 Apr 02;9(4):e91936 - PubMed
  35. Int J Neuropsychopharmacol. 2013 Aug;16(7):1673-85 - PubMed
  36. J Psychiatr Pract. 2014 May;20(3):232-6 - PubMed
  37. Drug Alcohol Depend. 1995 Feb;37(2):95-100 - PubMed
  38. Neuropharmacology. 2009 Apr;56(5):866-75 - PubMed
  39. Int Pharmacopsychiatry. 1981;16(2):119-23 - PubMed
  40. Neuropsychopharmacology. 2009 Sep;34(10):2344-57 - PubMed
  41. Eur J Pharmacol. 2000 Sep 29;405(1-3):365-73 - PubMed
  42. Rev Neurol. 2006 May 16-31;42(10):607-16 - PubMed
  43. Psychopharmacology (Berl). 2000 Aug;151(2-3):184-91 - PubMed
  44. J Neuropsychiatry Clin Neurosci. 2008 Winter;20(1):119-20 - PubMed
  45. Brain Res. 1990 Sep 17;527(2):234-43 - PubMed
  46. Alcohol Alcohol. 1999 May-Jun;34(3):283-8 - PubMed
  47. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1362-74 - PubMed
  48. Int J Geriatr Psychiatry. 2010 Oct;25(10):1030-8 - PubMed
  49. Int J Neuropsychopharmacol. 2013 May;16(4):783-9 - PubMed
  50. PLoS One. 2015 Apr 15;10(4):e0122131 - PubMed
  51. Compr Psychiatry. 1992 Mar-Apr;33(2):115-20 - PubMed
  52. Psychother Psychosom. 2013;82(3):197-9 - PubMed
  53. Ann Clin Psychiatry. 2012 May;24(2):119-26 - PubMed
  54. J Child Adolesc Psychopharmacol. 2007 Feb;17(1):19-33 - PubMed
  55. Ann N Y Acad Sci. 2002 Jun;965:233-46 - PubMed
  56. N Engl J Med. 2005 Jun 16;352(24):2515-23 - PubMed
  57. Naunyn Schmiedebergs Arch Pharmacol. 2004 Feb;369(2):228-31 - PubMed
  58. Int Clin Psychopharmacol. 2013 Mar;28(2):106-11 - PubMed
  59. Int J Geriatr Psychiatry. 2008 May;23(5):537-45 - PubMed
  60. Depress Res Treat. 2012;2012:485249 - PubMed
  61. BMJ Case Rep. 2011 Aug 04;2011:null - PubMed
  62. Brain Res. 2006 Apr 26;1085(1):77-86 - PubMed
  63. Neuroepidemiology. 2008;31(3):193-200 - PubMed
  64. Neurotox Res. 2002 Jun;4(4):373-91 - PubMed
  65. Neurochem Int. 2010 Sep;57(2):168-76 - PubMed
  66. Neurobiol Aging. 2006 Mar;27(3):413-22 - PubMed
  67. Acta Psychiatr Scand Suppl. 2007;(434):41-9 - PubMed
  68. Neuropharmacology. 2009 Jan;56(1):47-55 - PubMed
  69. Bipolar Disord. 2010 May;12(3):348-9 - PubMed
  70. Am J Psychiatry. 1994 Nov;151(11):1642-5 - PubMed
  71. Br J Psychiatry. 1994 Apr;164(4):549-50 - PubMed
  72. Acta Psychiatr Scand. 2010 Jun;121(6):404-14 - PubMed
  73. Eur J Pharmacol. 2004 May 10;492(1):61-3 - PubMed
  74. Nat Med. 2009 Dec;15(12):1355-6 - PubMed
  75. Pharmacol Biochem Behav. 2000 Oct;67(2):241-6 - PubMed
  76. Lancet. 2013 Nov 9;382(9904):1575-86 - PubMed
  77. Arch Gen Psychiatry. 1979 May;36(5):555-9 - PubMed
  78. Psychiatry Res. 2011 Aug 15;188(3):366-71 - PubMed
  79. Eur J Pharmacol. 2000 Apr 28;395(2):157-60 - PubMed
  80. J Neurosci. 1994 Mar;14(3 Pt 2):1735-45 - PubMed
  81. J Psychiatr Res. 2013 Oct;47(10):1343-8 - PubMed
  82. CNS Drugs. 2012 Aug 1;26(8):663-90 - PubMed
  83. Psychogeriatrics. 2013 Dec;13(4):254-9 - PubMed
  84. Eur J Pharmacol. 1997 Jul 2;330(1):11-4 - PubMed
  85. Clin Neuropharmacol. 2009 Jul-Aug;32(4):199-204 - PubMed
  86. Biol Psychiatry. 2008 Oct 15;64(8):718-26 - PubMed
  87. Evid Based Ment Health. 2008 Nov;11(4):113 - PubMed
  88. Behav Pharmacol. 2006 Feb;17(1):1-8 - PubMed
  89. J Clin Psychiatry. 2008 Mar;69(3):341-8 - PubMed
  90. World J Biol Psychiatry. 2013 May;14(4):291-8 - PubMed
  91. Curr Opin Pharmacol. 2006 Feb;6(1):61-7 - PubMed
  92. Biol Psychiatry. 2007 Jan 15;61(2):145-53 - PubMed
  93. Med Hypotheses. 2012 Aug;79(2):280-3 - PubMed
  94. Ann Pharmacother. 2006 Feb;40(2):344-6 - PubMed
  95. Brain Res Bull. 1996;40(3):201-7 - PubMed
  96. Drug Saf. 2008;31(7):577-85 - PubMed
  97. Pharmacol Biochem Behav. 1994 Jul;48(3):587-91 - PubMed
  98. J Alzheimers Dis. 2008 Jun;14(2):193-9 - PubMed
  99. CNS Spectr. 2008 Sep;13(9):790-5 - PubMed
  100. Eur Psychiatry. 2009 Mar;24(2):125-34 - PubMed
  101. Psychopharmacology (Berl). 2005 Apr;179(1):230-9 - PubMed
  102. Psychopharmacology (Berl). 2000 Aug;151(2-3):175-83 - PubMed
  103. J Affect Disord. 2012 Jan;136(1-2):163-6 - PubMed
  104. Int Pharmacopsychiatry. 1973;8(3):152-8 - PubMed
  105. Eur J Pharmacol. 1992 Dec 2;224(2-3):199-202 - PubMed
  106. Arch Gen Psychiatry. 1974 Feb;30(2):229-33 - PubMed
  107. Int Clin Psychopharmacol. 1997 Jul;12 Suppl 3:S7-14 - PubMed
  108. Eur J Pharmacol. 1981 Sep 11;74(2-3):195-206 - PubMed
  109. Am J Psychiatry. 2008 Mar;165(3):300-2 - PubMed
  110. Eur J Pharmacol. 2006 Mar 27;535(1-3):208-11 - PubMed
  111. J Atten Disord. 2017 Feb;21(4):343-352 - PubMed
  112. Life Sci. 1979 Jul 30;25(5):415-23 - PubMed
  113. Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53 - PubMed

Publication Types